News
Dr. Anne Peters Joins the Modular Medical Advisory Board
Dr. Peters, a prominent diabetes clinician and clinical researcher, is a leading voice in the fight to bring diabetes technology and therapeutics to under-resourced communitiesSAN DIEGO, CA / August 11, 2022 / Modular Medical, Inc. (the "Company" or "Modular...
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturingSAN DIEGO, CA / July 26, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that...
Modular Medical to Present at LD Micro Invitational XII Investor Conference
SAN DIEGO, CA / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical to Present at Spring Into Action – Best Ideas Virtual Investor Conference on May 18, 2022
SAN DIEGO, CA / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb...
Modular Medical Announces $8 Million Registered Direct Offering
SAN DIEGO, CA / May 3, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), today announced that it has entered into a securities purchase agreement with institutional investor Sio Capital Management (the "Investor") in connection with a...
Modular Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference
SAN DIEGO, CA / March 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today...
Modular Medical Appoints James “Jeb” Besser as Chief Executive Officer
Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MODD1 insulin pump to FDASAN DIEGO, CA / February 24, 2022 / Modular Medical, Inc. (the...
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market
SAN DIEGO, CA / February 10, 2022 / Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes...
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
SAN DIEGO, CA / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes...
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
SAN DIEGO, CA / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians...